A topological substructural approach for the prediction of P-glycoprotein substrates.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pharmacy and Science

• Publication date

  2006-03-01

• Fields of study

  Medicine, Chemistry, Mathematics

• Identifiers
  DOI 10.1002/JPS.20449PMID 16432877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.

  2004cited by this paper
• From Knowledge Generation to Knowledge Archive. A General Strategy Using TOPS-MODE with DEREK To Formulate New Alerts for Skin Sensitization

  2004cited by this paper
• A novel approach to predict a toxicological property of aromatic compounds in the Tetrahymena pyriformis.

  2004cited by this paper
• Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.

  2004cited by this paper
• How significant is the role of P-glycoprotein in drug absorption and brain uptake?

  2004cited by this paper
• Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach

  2004cited by this paper
• Towards P‐Glycoprotein Structure–Activity Relationships

  2004cited by this paper
• Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model.

  2004cited by this paper
• TOPS-MODE approach for the prediction of blood-brain barrier permeation.

  2004cited by this paper
• A topological sub-structural approach for predicting human intestinal absorption of drugs.

  2004cited by this paper
• In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS-MODE approach.

  2004cited by this paper
• Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro

  2003cited by this paper
• Improving Opportunities for Regulatory Acceptance of QSARs: The Importance of Model Domain, Uncertainty, Validity and Predictability

  2003cited by this paper
• Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.

  2003cited by this paper
• A topological-substructural molecular design (TOPS-MODE) approach to determining pharmacokinetics and pharmacological properties of 6-fluoroquinolone derivatives.

  2003cited by this paper
• On the Role of Polarizability in Chemical-Biological Interactions

  2003cited by this paper
• Quantitative structure-toxicity relationships using TOPS-MODE. 3. Structural factors influencing the permeability of commercial solvents through living human skin

  2003cited by this paper
• A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment.

  2002cited by this paper
• Kinetic characterization of secretory transport of a new ciprofloxacin derivative (CNV97100) across Caco-2 cell monolayers.

  2002cited by this paper
• A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

  2002cited by this paper
• In Silico Studies toward the Discovery of New Anti-HIV Nucleoside Compounds with the Use of TOPS-MODE and 2D/3D Connectivity Indices, 1. Pyrimidyl Derivatives

  2002cited by this paper
• Progress in understanding the structure-activity relationships of P-glycoprotein.

  2002cited by this paper
• Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs

  2002cited by this paper
• Modeling of active transport systems.

  2002cited by this paper
• Combination of 2D-, 3D-Connectivity and Quantum Chemical Descriptors in QSPR. Complexation of - and -Cyclodextrin with Benzene Derivatives

  2001cited by this paper
• Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P‐glycoprotein

  2001cited by this paper
• Polarizability Fields for Use in Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR)

  2001cited by this paper
• Rational use of in vitro P-glycoprotein assays in drug discovery.

  2001cited by this paper
• Combination of 2D-, 3D-connectivity and quantum chemical descriptors in QSPR. Complexation of alpha- and beta-cyclodextrin with benzene derivatives.

  2001cited by this paper
• A novel approach for the virtual screening and rational design of anticancer compounds.

  2000cited by this paper
• Mechanisms of Transport and Structure-Permeability Relationship of Sulfasalazine and Its Analogs in Caco-2 Cell Monolayers

  2000cited by this paper
• Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.

  2000cited by this paper
• Calculating partition coefficient by atom-additive method

  2000cited by this paper
• Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.

  2000cited by this paper
• In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.

  2000cited by this paper
• In silico studies for the rational discovery of anticonvulsant compounds.

  2000cited by this paper
• Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics.

  2000cited by this paper
• On the Topological Sub-Structural Molecular Design (TOSS-MODE) in QSPR/QSAR and Drug Design Research

  2000cited by this paper
• Progress in predicting human ADME parameters in silico.

  2000cited by this paper
• Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates

  1999cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• Secretion of Sparfloxacin from the Human Intestinal Caco-2 Cell Line Is Altered by P-Glycoprotein Inhibitors

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• Spectral Moments of the Edge-Adjacency Matrix of Molecular Graphs, 2. Molecules Containing Heteroatoms and QSAR Applications

  1997cited by this paper
• Absorption of ofloxacin isomers in the rat small intestine

  1997cited by this paper
• Collateral sensitivity of multidrug resistant cells to narcotic analgesics is due to effects on the plasma membrane.

  1995cited by this paper
• Fitting of nonlinear regressions by orthogonalized power series

  1993cited by this paper
• A two-step chirality transfer from (−)-endo- to (−)-exo-tricyclo[5.2.1.026]deca-4,8-dien-3-one

  1993cited by this paper
• Orthogonal molecular descriptors

  1991cited by this paper
• Correlation of enthalphy of octanes with orthogonal connectivity indices

  1991cited by this paper
• Resolution of ambiguities in structure-property studies by use of orthogonal descriptors

  1991cited by this paper
• Additivity methods in molecular polarizability

  1990cited by this paper
• SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

  1988cited by this paper
• Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions

  1987cited by this paper
• A new model for calculating atomic charges in molecules

  1978cited by this paper
• van der Waals Volumes and Radii

  1964cited by this paper
• The modern structural theory of organic chemistry

  1963cited by this paper
• Introduction General Considerations

  year unknowncited by this paper

• In Silico Screening of Hispolon and its Analogs: Pharmacokinetics and Molecular Docking Studies with Cyclooxygenase-2 Enzyme

  2021cites this paper
• Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2)

  2018cites this paper
• Drug Transporters as Therapeutic Targets: Computational Models, Challenges, and Future Perspective

  2018cites this paper
• Exploring the Chemical Space of P-Glycoprotein Interacting Compounds.

  2017cites this paper
• The natural anti-tubercular agents : In silico study of physicochemical , pharmacokinetic and toxicological properties

  2017cites this paper
• Modelling Cellular Permeability via Carrier Mediated Transport

  2016cites this paper
• Estudio de la modificación en la absorción de fármacos en giardiasis y nuevas estrategias de formulación

  2016cites this paper
• Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human $$\mathbf{A}_{3}$$A3 adenosine receptor ligands

  2016cites this paper
• Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks

  2015cites this paper
• MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks

  2015cites this paper
• Desarrollo de una metodología "in silico" para el diseño de nuevos antagonistas de receptores de adenosina

  2015cites this paper
• Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer.

  2015cites this paper
• In silico ADME/T modelling for rational drug design

  2015cites this paper
• Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.

  2015cites this paper
• In silico model for predicting soil organic carbon normalized sorption coefficient (K(OC)) of organic chemicals.

  2015cites this paper
• Identifying the CmbT substrates specificity by using a quantitative structure–activity relationship (QSAR) study

  2014cites this paper
• Computational identification of RNA functional determinants by three-dimensional quantitative structure–activity relationships

  2014cites this paper
• ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates.

  2014cites this paper
• Target Based Designing of Anthracenone Derivatives as Tubulin Polymerization Inhibiting Agents: 3D QSAR and Docking Approach

  2014cites this paper
• Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen.

  2013cites this paper
• Quantification de la relation séquence-activité de l’ARN par prédiction de structure tridimensionnelle

  2013cites this paper
• Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions

  2013cites this paper
• Computational models for predicting interactions with membrane transporters.

  2013cites this paper
• Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein

  2013cites this paper
• CNS drug development - lost in translation?

  2012cites this paper
• Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays

  2012cites this paper
• Research Paper Information rich Descriptors for Predicting P-Glycoprotein Substrates and Non- substrates: A Binary-QSAR approach

  2012cites this paper
• QSAR Models for P-Glycoprotein Transport Based on a Highly Consistent Data Set

  2012cites this paper
• QSAR study of liver specificity of carcinogenicity of N-nitroso compounds.

  2012cites this paper
• Computational models for predicting substrates or inhibitors of P-glycoprotein.

  2012cites this paper
• QSPR in oral bioavailability: specificity or integrality?

  2012cites this paper
• Development and application of distributed computing tools for virtual screening of large compound libraries

  2012cites this paper
• Liver specificity of the carcinogenicity of NOCs: a chemical-molecular perspective.

  2012cites this paper
• Prediction Models of P-Glycoprotein Substrates Using Simple 2D and 3D Descriptors by a Recursive Partitioning Approach

  2012cites this paper
• P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set

  2011cites this paper
• Predicting Binding to P-Glycoprotein by Flexible Receptor Docking

  2011cites this paper
• An in vitro evaluation of guanfacine as a substrate for P-glycoprotein

  2011cites this paper
• Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein

  2011cites this paper
• Predicting carcinogenicity and understanding the carcinogenic mechanism of N-nitroso compounds using a TOPS-MODE approach.

  2011cites this paper
• Use of shape similarities for the classification of P-glycoprotein substrates and nonsubstrates.

  2011cites this paper
• PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.

  2011cites this paper
• The QSARome of the receptorome: Quantitative structure-activity relationship modeling of multiple ligand sets acting at multiple receptors

  2011cites this paper
• Development of a highly specific ensemble of topological models for early identification of P‐glycoprotein substrates

  2011cites this paper
• Drug Design: Predicting ADME properties in drug discovery

  2010cites this paper
• Ensemble Rule‐Based Classification of Substrates of the Human ABC‐Transporter ABCB1 Using Simple Physicochemical Descriptors

  2010cites this paper
• Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo.

  2010cites this paper
• Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach.

  2010influential citation
• Targeting intestinal transporters for optimizing oral drug absorption.

  2010cites this paper
• In Silico Approaches for Predicting Adme Properties

  2010influential citation
• Design of novel antituberculosis compounds using graph-theoretical and substructural approaches

  2009cites this paper
• ABC Transporters – From Targets to Antitargets?

  2009cites this paper
• Quantitative Structure Activity Relationship (QSAR) Approach to Multiple Drug Resistance (MDR) Modulators Based on Combined Hybrid System

  2009cites this paper
• QSAR analysis and molecular modeling of ABCG2-specific inhibitors.

  2009cites this paper
• Similarity Based Descriptors – Useful for Classification of Substrates of the Human Multidrug Transporter P‐Glycoprotein?

  2009cites this paper
• A TOPological Sub-structural Molecular Design (TOPS-MODE)-QSAR approach for modeling the antiproliferative activity against murine leukemia tumor cell line (L1210).

  2009cites this paper
• Support Vector Machine Classifier for Predicting Drug Binding to P-glycoprotein

  2009influential citation
• Amyloid Beta Transport and Effects on Permeability in a Human Brain Endothelial Cell Line

  2009cites this paper
• Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123.

  2009cites this paper
• A Dual-Fluorescence High-Throughput Cell Line System for Probing Multidrug Resistance

  2009cites this paper
• Modeling of drug-transporter interactions using structural information.

  2008cites this paper
• Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

  2008cites this paper
• In silico prediction of substrate properties for ABC-multidrug transporters.

  2008cites this paper
• Computational models for prediction of interactions with ABC-transporters.

  2008cites this paper
• Toward Understanding P‐Glycoprotein Structure–Activity Relationships

  2008cites this paper
• How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design.

  2008cites this paper
• In silico prediction of substrate properties for ABC-multidrug transporters

  2008cites this paper
• "In silico" prediction of blood-brain barrier permeation and P-glycoprotein activity

  2008cites this paper
• Quantum-chemical foundations of the topological substructural molecular design.

  2008cites this paper
• Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm

  2007cites this paper
• A primer on the mechanics of P-glycoprotein the multidrug transporter.

  2007cites this paper
• Chapter 29 Computational Models for ADME

  2007cites this paper
• Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery.

  2006cites this paper